GB9201749D0 - Medicaments - Google Patents
MedicamentsInfo
- Publication number
- GB9201749D0 GB9201749D0 GB929201749A GB9201749A GB9201749D0 GB 9201749 D0 GB9201749 D0 GB 9201749D0 GB 929201749 A GB929201749 A GB 929201749A GB 9201749 A GB9201749 A GB 9201749A GB 9201749 D0 GB9201749 D0 GB 9201749D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- medicaments
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/08—Bridged systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
- C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/08—Bridged systems
Priority Applications (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB929201749A GB9201749D0 (en) | 1992-01-28 | 1992-01-28 | Medicaments |
ZA93550A ZA93550B (en) | 1992-01-28 | 1993-01-26 | Azabricyclic compounds as calcium channel antagonists |
MX9300407A MX9300407A (es) | 1992-01-28 | 1993-01-26 | Derivados azabiciclicos usados en la fabricacion de medicamentos, composiciones que los contienen y procedimiento para su preparacion. |
JP5513049A JPH07503463A (ja) | 1992-01-28 | 1993-01-27 | カルシウムチャンネル拮抗薬としてのアザビシクロ化合物 |
PCT/GB1993/000175 WO1993015073A1 (en) | 1992-01-28 | 1993-01-27 | Azabricyclic compounds as calcium channel antagonists |
EP93902471A EP0625979A1 (en) | 1992-01-28 | 1993-01-27 | Azabricyclic compounds as calcium channel antagonists |
AU33646/93A AU3364693A (en) | 1992-01-28 | 1993-01-27 | Azabricyclic compounds as calcium channel antagonists |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB929201749A GB9201749D0 (en) | 1992-01-28 | 1992-01-28 | Medicaments |
Publications (1)
Publication Number | Publication Date |
---|---|
GB9201749D0 true GB9201749D0 (en) | 1992-03-11 |
Family
ID=10709348
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB929201749A Pending GB9201749D0 (en) | 1992-01-28 | 1992-01-28 | Medicaments |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP0625979A1 (es) |
JP (1) | JPH07503463A (es) |
AU (1) | AU3364693A (es) |
GB (1) | GB9201749D0 (es) |
MX (1) | MX9300407A (es) |
WO (1) | WO1993015073A1 (es) |
ZA (1) | ZA93550B (es) |
Families Citing this family (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9122988D0 (en) * | 1991-10-30 | 1991-12-18 | Ici Plc | Heterocyclic compounds |
GB9127279D0 (en) * | 1991-12-23 | 1992-02-19 | Ici Plc | Heterocyclic derivatives |
CA2093778A1 (en) * | 1992-04-10 | 1993-10-11 | George R. Brown | Heterocyclic compounds |
GB9211796D0 (en) * | 1992-06-04 | 1992-07-15 | Ici Plc | Heterocyclic derivatives |
GB9216721D0 (en) * | 1992-08-06 | 1992-09-23 | Ici Plc | Therapeutic heterocyclic derivatives |
GB9218334D0 (en) * | 1992-08-28 | 1992-10-14 | Ici Plc | Heterocyclic compounds |
CA2110251A1 (en) * | 1992-11-30 | 1994-05-31 | Koichi Fujimoto | Alpha, omega-diarylalkane derivatives, their preparation and their use in the treatment and prevention of circulatory diseases and psychosis |
GB9226573D0 (en) * | 1992-12-21 | 1993-02-17 | Ici Plc | Heterocyclic compounds |
IL109451A0 (en) * | 1993-04-29 | 1994-07-31 | Zeneca Ltd | Heterocyclic derivatives |
GB9314973D0 (en) * | 1993-07-20 | 1993-09-01 | Smithkline Beecham Plc | Medicaments |
GB9410441D0 (en) * | 1994-05-25 | 1994-07-13 | Erba Carlo Spa | Azabicycloakyl derivatives of imidazo (1,5-a) indol-3-one and process for their preparation |
HUP9801361A3 (en) * | 1995-03-02 | 1998-10-28 | Yamanouchi Pharma Co Ltd | Novel quinuclidine derivatives having tricyclic fused hetero ring |
RU2138268C1 (ru) * | 1997-09-22 | 1999-09-27 | Мосин Владимир Александрович | Средство, подавляющее пролиферацию и вызывающее гибель опухолевых клеток, при этом защищающее нормальные клетки |
US6251919B1 (en) | 1998-02-27 | 2001-06-26 | Warner-Lambert | Heterocyclic substituted aniline calcium channel blockers |
US6166052A (en) | 1998-03-11 | 2000-12-26 | Warner-Lambert Company | Heteroaryl alkyl alpha substituted peptidylamine calcium channel blockers |
DE10164139A1 (de) | 2001-12-27 | 2003-07-10 | Bayer Ag | 2-Heteroarylcarbonsäureamide |
US7094789B2 (en) | 2002-07-22 | 2006-08-22 | Asahi Kasei Pharma Corporation | 5-substituted isoquinoline derivatives |
DE10234424A1 (de) | 2002-07-29 | 2004-02-12 | Bayer Ag | Benzothiophen-, Benzofuran- und Indolharnstoffe |
NZ538058A (en) * | 2002-08-14 | 2006-11-30 | Neurosearch As | Quinuclidine derivatives and their use for treating disorders related to CNS and PNS |
DE602004031124D1 (de) | 2003-08-13 | 2011-03-03 | Neurosearch As | Neue chinuklidinderivative und deren pharmazeutische verwendung |
US7365193B2 (en) | 2004-02-04 | 2008-04-29 | Abbott Laboratories | Amino-substituted tricyclic derivatives and methods of use |
US20050171079A1 (en) * | 2004-02-04 | 2005-08-04 | Schrimpf Michael R. | Amino-substituted tricyclic derivatives and methods of use |
US7417040B2 (en) | 2004-03-01 | 2008-08-26 | Bristol-Myers Squibb Company | Fused tricyclic compounds as inhibitors of 17β-hydroxysteroid dehydrogenase 3 |
GB0415746D0 (en) | 2004-07-14 | 2004-08-18 | Novartis Ag | Organic compounds |
AU2011256287B2 (en) | 2010-05-17 | 2016-11-10 | Envivo Pharmaceuticals, Inc. | A crystalline form of (R)-7-chloro-N-(quinuclidin-3-yl)benzo[b]thiophene-2-carboxamide hydrochloride monohydrate |
RU2017136693A (ru) | 2012-05-08 | 2019-02-08 | Форум Фармасьютикалз, Инк. | Способы поддержания, лечения или улучшения когнитивной функции |
ES2715050T3 (es) * | 2014-05-28 | 2019-05-31 | Toa Eiyo Ltd | Derivados de tropano sustituidos |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ227684A (en) * | 1988-01-30 | 1991-07-26 | Merck Sharp & Dohme | Pyrazine, pyridazine, and pyrimidine derivatives and pharmaceutical compositions |
GB8918060D0 (en) * | 1989-08-08 | 1989-09-20 | Merck Sharp & Dohme | Therapeutic agents |
GB8918061D0 (en) * | 1989-08-08 | 1989-09-20 | Merck Sharp & Dohme | Therapeutic agents |
DK72790D0 (da) * | 1990-03-21 | 1990-03-21 | Ferrosan As | Heterocycliske forbindelser, deres fremstilling og anvendelse |
GB9017353D0 (en) * | 1990-08-08 | 1990-09-19 | Merck Sharp & Dohme | Chemical process |
CA2050264A1 (en) * | 1990-08-30 | 1992-03-01 | Raymond Baker | Substituted pyrazine and its salts, compositions containing them and their use in medicine |
EP0492904A1 (en) * | 1990-12-21 | 1992-07-01 | MERCK SHARP & DOHME LTD. | Substituted benzene derivatives for use in the treatment of glaucoma |
EP0492902A1 (en) * | 1990-12-21 | 1992-07-01 | MERCK SHARP & DOHME LTD. | Substituted pyridine derivatives for use in the treatment of glaucoma |
EP0492903A1 (en) * | 1990-12-21 | 1992-07-01 | MERCK SHARP & DOHME LTD. | Substituted pyrazines, pyrimidines and pyridazines for use in the treatment of glaucoma |
ZA92278B (en) * | 1991-02-01 | 1992-10-28 | Akzo Nv | 3-quinuclidine derivatives |
JPH06506467A (ja) * | 1991-03-08 | 1994-07-21 | ローヌ−プーラン ローラー インターナショナル(ホウルディングス) インコーポレイテッド | 多環式三級アミンポリ芳香族スクアレンシンセターゼインヒビター |
-
1992
- 1992-01-28 GB GB929201749A patent/GB9201749D0/en active Pending
-
1993
- 1993-01-26 ZA ZA93550A patent/ZA93550B/xx unknown
- 1993-01-26 MX MX9300407A patent/MX9300407A/es unknown
- 1993-01-27 WO PCT/GB1993/000175 patent/WO1993015073A1/en not_active Application Discontinuation
- 1993-01-27 AU AU33646/93A patent/AU3364693A/en not_active Abandoned
- 1993-01-27 EP EP93902471A patent/EP0625979A1/en not_active Withdrawn
- 1993-01-27 JP JP5513049A patent/JPH07503463A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
MX9300407A (es) | 1994-07-29 |
AU3364693A (en) | 1993-09-01 |
WO1993015073A1 (en) | 1993-08-05 |
ZA93550B (en) | 1994-07-26 |
JPH07503463A (ja) | 1995-04-13 |
EP0625979A1 (en) | 1994-11-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AP9300484A0 (en) | Medicaments | |
GB9201749D0 (en) | Medicaments | |
GB9308430D0 (en) | Medicaments | |
ZA939317B (en) | Medicament | |
ZA935522B (en) | Medicaments | |
GB9315566D0 (en) | Medicaments | |
GB9313574D0 (en) | Medicaments | |
GB9314973D0 (en) | Medicaments | |
GB9224739D0 (en) | Medicaments | |
GB9202522D0 (en) | Medicaments | |
GB9313649D0 (en) | Medicaments | |
GB9207590D0 (en) | Medicaments | |
GB9215749D0 (en) | Medicaments | |
GB9216857D0 (en) | Medicaments | |
GB9216381D0 (en) | Medicaments | |
GB9211803D0 (en) | Medicaments | |
GB9211802D0 (en) | Medicaments | |
GB9210306D0 (en) | Medicaments | |
GB9219301D0 (en) | Medicaments | |
GB9206083D0 (en) | Medicaments | |
GB9205980D0 (en) | Medicaments | |
GB9205139D0 (en) | Medicaments | |
GB9204151D0 (en) | Medicaments | |
GB9202523D0 (en) | Medicaments | |
GB9219318D0 (en) | Medicaments |